Clinically Proven: LipoAvail® Boosts NAD+, VC & GSH

Overview


Effepharm

Only few liposomal brands can claim both animal and human clinical validation. While our clinically proven LipoAvail® liposomal series boosts bioavailability: NAD+ by 1.5×, VC by 1.65×, and GSH absorption by 1.38×.

NAD+ supports anti-ageing and metabolism. Our VC & GSH are boost for your skin’s radiance and antioxidant defense —they are all science-backed nutrition solution.

Liposomes encapsulate active ingredients, mimicking cell membranes for better absorption & efficacy.

Download the White Paper to find secrets of Liposomal technology, and discover more clinically backed LipoAvail® products.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Official: Uthever® NMN Secures FDA NDI Clearance

Official: Uthever® NMN Secures FDA NDI Clearance

Content provided by Effepharm Ltd

White Paper

Why choose Uthever®? Stronger compliance: Uthever® has secured an FDA NDI notification (NDI 1267), confirming the compliance of its NMN ingredient.

Clinically Proven: LipoAvail® Boosts VC & GSH

Clinically Proven: LipoAvail® Boosts VC & GSH

Content provided by Effepharm Ltd

White Paper

LipoAvail® VC & GSH are more than just a boost for your skin’s radiance and antioxidant defense—they are a science-backed brightening solution.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.